Search Results
Genetic Approaches to Identify and Treat Cancer Patients at High Risk for Cardiotoxicity
Pharmacogenomic Prediction of Antracycline-induced Cardiotoxicity
“Past, Present and Future Ways to Detect Cardiotoxicity”
Keynote Lecturer Christine Seidman on Genetic Approaches to Cardiomyopathy
Anthracycline Cardiotoxicity: The Role of Cardio-Oncology in Management
Marie A Chaix - AI approaches to predicting cardiotoxicity
Harnessing Genetics to Identify Druggable Targets and Causes of Off-Target Cardiotoxicity
Cardiovascular Recovery in Anthracycline Cardiotoxicity
Cardiac biomarkers and genetics in cardio-oncology: from bench to bedside
Cardiovascular toxicityCard of targeted cancer therapies - B. Jensen - 20190925
Cardiac Dysfunction in Breast Cancer Patients: Monitoring, Diagnosis, and Treatment
Connecting Cardio & Cancer: Mitigating Cardiotoxicity with Optimized Treatment Strategies
